VERNON, BC, November 25, 2022 /CNW/ – Dosology Sciences Inc. (CSE: VIBE) (OTCQB: DOSEF) (ESF: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is thrilled to announce that its functional mushroom supplements will soon be available nationwide in the 14 premier locations of Whole Foods Market Canada.
The company launched with 3 leading SKUs – SLEEP, WAKE and ELEVATE functional mushroom tinctures. Doseology products can currently be found at Whole Foods Market Western outlets at West Vancouver, North Vancouver, Vancouverand Burnaby Northand will soon be available at all retail outlets in Canada.
“Whole Foods has a reputation for being an industry leader with the highest standards, making it an ideal retail partner for our products. This placement will help us build brand awareness and increase sales, while delivering health and wellness results to customers,” said Ralph OlsonCompany CEO.
The line is made from 100% fruiting mushrooms and adaptogenic herbs, and is designed for wellness seekers interested in daily support for cognition, mood, immunity and relaxation .
Approximately 30% of Canadians suffer from a sleep disorder (The Sleep Foundation). Sleep affects mental health and physical well-being and is linked to most mood disorders, including depression and anxiety (Provincial Health Services Authority). To solve this problem, Doseology formulated its SLEEP dyeing. The exclusive blend of reishi mushrooms, chamomile and melatonin is a powerful tool that brings the body and mind into a state of rest and improves the quality of sleep. Reishi mushroom (Ganoderma lucidum), also known as the “Mushroom of Immortality”, has been used for centuries to relieve stress and anxiety.
The mornings are boosted with Doseology WAKE dyeing. It’s an energizing blend of lion’s mane mushroom, yerba mate and B vitamins to promote wakefulness and mental clarity. Wake was recently seen in “Elle Gourmet”Four surprising wellness trends for 2023“.
Dosage RAISE The tincture contains Lion’s Mane, the fungus known to unlock cognitive potential, and is formulated with a nutrient-dense dose of ginger and vitamin B3. These carefully stacked ingredients work synergistically to provide overall mood support.
On behalf of Doseology Sciences Inc.
Ralph Olson
Chief executive officer
About Whole Foods Market
For over 40 years, Whole Foods Market has been a leading natural and organic food retailer. Whole Foods sources the best natural and organic foods available, maintains the highest quality standards in the industry, and has an unwavering commitment to sustainable agriculture. Whole Foods has over 500 stores in the United States, Canada and the UK. It has 14 points of sale in Canadaof which 7 are in British Columbiaand 7 are in Ontario. Whole Foods is a subsidiary of Amazon (Nasdaq: AMZN).
About the science of doseology (CSE: MOOD) (OTCQB: DOSEF) (ESF: VU7)
Doseology Sciences Inc. is building a progressive brand focused on mental health and wellness through cultivation, extraction, and innovative nutraceuticals and pharmaceuticals. Doseology aims to make a significant impact on the mental health pandemic by using and developing functional mushrooms and plant-derived medicines. With a vertically integrated approach, Doseology intends to process and distribute products through its facilities in Vernon, British Columbia, in accordance with applicable laws to ensure safe and high-quality production. Doseology’s medicinal mushroom products, including tinctures, powders and supplements, are available at doseology.com.
Website: doseology.com
Forward-looking statements
This press release contains statements that constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is often identified by the words “may”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, ” wait” or similar expressions. Readers are cautioned that forward-looking information is not based on historical facts, but rather reflects the Company’s management’s expectations, estimates or projections regarding the business of future results or events of the Company based on opinions, management’s assumptions and estimates considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes in financial markets; declines in prevailing prices for products in the markets in which the Company operates; adverse changes in applicable laws or adverse changes in the application or enforcement of applicable laws; regulations and enforcement priorities of governmental authorities; compliance with government regulations and related costs; and other risks described in the Company’s prospectus. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may differ materially from those described herein as anticipated, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be those anticipated, estimated or planned. The Company does not intend and undertakes no obligation to update this forward-looking information, except as otherwise required by applicable law. For further information, investors should consult the documents filed by the Company which are available at REALIZE.
No securities regulatory authority has approved or disapproved of the contents of this press release. The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities law, and may not be offered or sold in United Statesor to or for the account or benefit of any person in United States, lack of registration or applicable exemption from registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities of United Statesor in any other jurisdiction in which such offer, solicitation or sale would be unlawful.
CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Dosology Sciences inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2022/25/c5549.html
#Doseology #national #Foods #Market